Delivering the latest trends shaping science, biotech, and healthcare — showcasing work that drives revenue, reputation, and investment for compelling brands — and offering an inside look at the award-winning culture behind it all.
HDMZ had the privilege of co-sponsoring the 2025 Science2Startup symposium, and mentoring some of the groundbreaking startups that presented there. Check out what our mentees are working on, and the challenges and opportunities currently facing the biotech startup community.
At the 2025 ASGCT meeting, researchers from the Children’s Hospital of Philadelphia and the University of Pennsylvania presented the development and administration of a personalized CRISPR therapy – all accomplished within six months – for KJ Muldoon, an infant diagnosed with CPS1 deficiency. This rapid achievement was made possible through key collaborations with Aldevron and Integrated DNA Technologies, along with Acuitas Therapeutics, which provided the lipid nanoparticle delivery system and helped manufacture the drug product, enabling three escalating doses. In partnership with HDMZ, Acuitas helped elevate awareness of this case, highlighting the future potential of personalized gene editing therapies. A truly inspiring story.
How do you measure brand health as a science marketer? Find out what metrics you should be tracking according to one panel of industry experts, including HDMZ’s CEO Dillon Allie.
.png?upscale=true&width=1200&upscale=true&name=image%20(36).png)
.png?upscale=true&width=1120&upscale=true&name=image%20(39).png)
.jpg?upscale=true&width=800&upscale=true&name=events%20post%20(2).jpg)
